Small Correspondence
Comments on Total Platinum Concentration and Platinum Oxidation States in Body Fluids, Tissue, and Explants from Women Exposed to Silicone and Saline Breast Implants by IC−ICPMS
Fax: +1 (989) 496-5956. Tel: +1 (989) 496-4181. E-mail: tom.lane@ dowcorning.com.
The author has presented the chemistry associated with silicone breast implants at the FDA, The National Academy of Sciences Institute of Medicine, National Institute of Cancer, and several other similar venues. The author has not served as an expert witness in any silicone breast implant litigation. The Dow Corning Corporation has not manufactured silicone breast implants since 1992.
Abstract
The paper by Lykissa and Maharaj (Lykissa, E. D.; Maharaj, S. V. M Anal. Chem. 2006, 78, 2925−2933) purports to provide evidence that the urine of women with silicone breast implants contain 60 to over 1700 times more platinum in their urine that the urine of people with no known exposure to platinum. Further, they purport to show evidence that the platinum used in the manufacture of breast implants (Pt0) is converted by a unknown process to yield highly oxidized platinum species, stable in biological matrixes, up to and including Pt6+. This correspondence poses three questions associated with the work and directs the reader's attention to the data, which clearly show that the blood and urine platinum levels in implanted women and their healthy control group were not significantly different from one another.
View: Full Text HTML | Hi-Res PDF
Tools
-
Add to Favorites
-
Download Citation
-
Email a Colleague -
Permalink
Order Reprints
Rights & Permissions
Citation Alerts
History
- Published In Issue August 01, 2006
- Received for review April 21, 2006. Accepted May 30, 2006.
Cart


